1. Home
  2. EJH vs XBIO Comparison

EJH vs XBIO Comparison

Compare EJH & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo E-Home Household Service Holdings Limited

EJH

E-Home Household Service Holdings Limited

N/A

Current Price

$1.30

Market Cap

4.2M

ML Signal

N/A

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$1.87

Market Cap

4.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EJH
XBIO
Founded
2018
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.7M
IPO Year
2019
2011

Fundamental Metrics

Financial Performance
Metric
EJH
XBIO
Price
$1.30
$1.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.3K
★ 23.5K
Earning Date
11-17-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.52
EPS
★ N/A
N/A
Revenue
N/A
★ $2,976,411.00
Revenue This Year
N/A
$2.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 19.04
52 Week Low
$0.08
$1.58
52 Week High
$3.07
$4.94

Technical Indicators

Market Signals
Indicator
EJH
XBIO
Relative Strength Index (RSI) 48.23 34.68
Support Level $1.26 $1.58
Resistance Level $1.35 $2.53
Average True Range (ATR) 0.13 0.18
MACD -0.00 0.03
Stochastic Oscillator 48.28 25.77

Price Performance

Historical Comparison
EJH
XBIO

About EJH E-Home Household Service Holdings Limited

E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving orders online and providing services offline. Its operations are organized into four reportable segments: appliance installation and maintenance services, housekeeping services, senior care services, and educational consulting services. The company generates the majority of its revenue from installation and maintenance.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Share on Social Networks: